This track will explore the role of protein kinases in the regulation of signal transduction pathways involved in cancer. Discussions will focus on their potential as therapeutic targets and the implications for cancer treatment.

This session will examine the interactions between steroid hormones and their receptors in the context of cancer biology. Emphasis will be placed on understanding their roles in tumor progression and therapeutic strategies.

This track will highlight the use of transgenic mice as models for studying cancer development and progression. Participants will discuss advancements in genetic engineering techniques and their applications in cancer research.

This session will delve into the mechanisms of apoptosis and their dysregulation in cancer cells. The focus will be on therapeutic approaches that aim to restore apoptotic pathways in tumors.

This track will cover the applications of RNA interference technology in cancer biology and treatment. Researchers will present innovative strategies for utilizing RNAi to target oncogenes and enhance therapeutic efficacy.

This session will explore the role of viral infections in the initiation and progression of cancer. Discussions will include the mechanisms by which viruses contribute to carcinogenesis and potential therapeutic interventions.

This track will focus on the molecular mechanisms underlying carcinogenesis and mutagenesis. Participants will share insights into genetic and environmental factors that contribute to cancer development.

This session will highlight recent advancements in cancer science, including novel therapeutic approaches and technologies. The goal is to foster discussions on integrating these advancements into clinical practice.

This track will emphasize the importance of integrative methodologies in cancer research, combining various disciplines to enhance understanding and treatment of cancer. Participants will discuss case studies and collaborative efforts.

This session will explore the role of metabolomics in understanding cancer biology and its potential for identifying biomarkers. Researchers will present findings on metabolic alterations in cancer cells and their implications for therapy.

This track will focus on novel approaches to anti-cancer drug discovery and development. Participants will discuss cutting-edge research, including high-throughput screening and targeted therapies.